4//SEC Filing
Leuthner Brian A 4
Accession 0001127602-18-021574
CIK 0001472091other
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 4:22 PM ET
Size
5.2 KB
Accession
0001127602-18-021574
Insider Transaction Report
Form 4
Leuthner Brian A
Chief Executive Officer
Transactions
- Award
Stock Option (Right To Purchase)
2018-06-19+338,068→ 338,068 totalExercise: $1.10→ Common Stock (338,068 underlying)
Footnotes (2)
- [F1]These options shall become exercisable upon the achievement of certain performance or time based criteria.
- [F2]These options expire on the third anniversary of the vesting date.
Documents
Issuer
Edge Therapeutics, Inc.
CIK 0001472091
Entity typeother
Related Parties
1- filerCIK 0001652973
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 4:22 PM ET
- Size
- 5.2 KB